Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ES-4000 by Escend Pharmaceuticals for Melanoma: Likelihood of Approval
ES-4000 is under clinical development by Escend Pharmaceuticals and currently in Phase I for Melanoma. According to GlobalData, Phase I...
Data Insights
ES-4000 by Escend Pharmaceuticals for Metastatic Breast Cancer: Likelihood of Approval
ES-4000 is under clinical development by Escend Pharmaceuticals and currently in Phase I for Metastatic Breast Cancer. According to GlobalData,...